Sign In
Buy CPRX
$31.28
+0.0100 (+0.0320%)
At Close: Jun 03, 2026
Catalyst (CPRX) Beats on Q4 Earnings, Revenues Rise Y/Y
09:06am, Tuesday, 16'th Mar 2021
Catalyst's (CPRX) earnings and revenues beat estimates in the fourth quarter of 2020.
Catalyst Pharmaceutical (CPRX) Beats Q4 Earnings and Revenue Estimates
07:17pm, Monday, 15'th Mar 2021
Catalyst (CPRX) delivered earnings and revenue surprises of 22.22% and 3.17%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
05:26pm, Monday, 15'th Mar 2021
- Firdapse® Q4-20 Net Revenues of $31.0 Million, FY-20 Net Revenues of $119.1 Million
Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth
01:38pm, Monday, 08'th Mar 2021
Catalyst (CPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CORAL GABLES, Fla., March 04, 2021 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing
Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2021
08:03am, Monday, 22'nd Feb 2021
CORAL GABLES, Fla., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing i
7 Penny Stock Companies That Actually Make Money
01:37pm, Friday, 19'th Feb 2021
Penny stocks are low price for a reason. Most presume they're destined for bankruptcy.
Catalyst Pharma, TherapeuticsMD May Be Next WallStreetBets Targets
07:37am, Friday, 29'th Jan 2021
Now that AMC, GameStop, American Airlines and Bed, Bath & Beyond have been pushed to wild levels, well above any sane valuation, the question is which companies will be the next to be “recommended�
3 Top Small-Cap Stocks to Buy in January
06:13am, Saturday, 09'th Jan 2021
Investors can start the new year off right by digging into these three small but fiery stocks.
Catayst (CPRX) Provides Long-Term Portfolio Expansion Plans
12:02pm, Thursday, 07'th Jan 2021
Catalyst (CPRX) plans to expand its product portfolio beyond Firdapse.
3 Non-Cyclical Stocks to Consider
11:37am, Wednesday, 06'th Jan 2021
Investors focused on assets with high returns may want to consider the following non-cyclical stocks, as their earnings yields (as calculated through Joel Greenblatt's method) are outperforming the S&
Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update
08:07am, Wednesday, 06'th Jan 2021
CORAL GABLES, Fla., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing i
Catalyst Pharmaceuticals: Attractive Valuation Has Priced In Risks
06:55am, Wednesday, 30'th Dec 2020
Catalyst Pharma is a commercial-stage small biotech with a highly profitable orphan drug Firdapse for adult LEMS patients in the US market. Catalyst Pharma is trading at PE ratio of 5 and price-to-sal
A+ Top Quant Rated Healthcare Stocks For Value, Growth, And Profitability
08:38am, Wednesday, 23'rd Dec 2020
Three referenced quant rating categories (value, growth, and profitability) are significant considerations in selecting healthcare investments. The data underlying the value, growth, and profitability
Catalyst Pharmaceuticals (CPRX) Jumps: Stock Rises 5.5%
09:47am, Tuesday, 15'th Dec 2020
Catalyst Pharmaceuticals (CPRX) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
